Streetbeat News

Revenues

GILT

Gilat Satellite Networks Ltd. (NASDAQ: GILT) has secured over $14 million in orders for its In-Flight Connectivity (IFC) solutions from several prominent service providers and system integrators. This strengthens Gilat's leadership in the IFC market, further bolstered by its recent acquisition of Stellar Blu Solutions.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:04 am

SMPL

Simply Good Foods (NASDAQ:SMPL) reported Q3 earnings of $0.50 per share, beating the estimate of $0.48. However, sales of $334.76M missed the $337.66M estimate.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:01 am

ETHE

GBTC

Galaxy Research projects that Ethereum ETFs could attract significant capital, potentially reshaping the Ethereum ecosystem. The report estimates net inflows into ETH ETFs to be 20-50% of BTC ETF inflows, with a target of $1 billion/month. The SEC has approved applicant filings, but S-1 filings are still pending. The conversion of the Grayscale Ethereum Trust into an ETF is also expected to influence market dynamics.

Portfolio Pulse from Murtuza Merchant

June 27, 2024 | 11:01 am

TH

Target Hospitality anticipates achieving zero net debt by the end of 2024, with over $350 million of total available liquidity.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:59 am

TH

Target Hospitality has revised its FY24 total revenue outlook downwards from $410M-$425M to $375M-$385M, below the estimated $396.10M. This revision follows the termination of the STFRC Contract and other factors.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:58 am

ELAN

Elanco Animal Health has raised its innovation sales outlook for 2024 from $375M-$410M to $400M-$450M and expects innovation sales of $600M-$700M by the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:39 am

APOG

Apogee Enterprises has reaffirmed its FY25 outlook, projecting a decline in net sales by 4% to 7%.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:38 am

ZOM

Zomedica Corp. (NYSE:ZOM) has launched a new cortisol assay for equine health on its TRUFORMA diagnostic platform. This new tool allows equine veterinarians to measure cortisol levels in foals at the point of care, enabling real-time, potentially life-saving treatment decisions. The TRUFORMA platform addresses a $1.5 billion annual recurring revenue opportunity in the US and is expanding into the European market.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:35 am

MKC

McCormick reaffirms its FY24 outlook, expecting sales to range from -2% to 0% and adjusted EPS of $2.80 to $2.85. The company anticipates improved volume trends and strong cash flow, with significant returns to shareholders through dividends.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 10:34 am

MU

Micron Technology's stock dropped over 5% in pre-market trading despite beating Q3 revenue and EPS estimates. The decline is attributed to minor profit booking. The company's AI prospects remain strong, with expected growth in High Bandwidth Memory (HBM) revenue. Micron is also set to benefit from the CHIPS Act.

Portfolio Pulse from Benzinga Neuro

June 27, 2024 | 10:33 am